Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target IGF1R (clone B3). We employs the Lentivirus (EF1α-Cy3-IL-10-EcoRI) vector components and the SynExpress system of the Exons Inversion/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
IGF1R
Clone
B3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
EF1α
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.85
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.